Mercy BioAnalytics, Inc. – Trademark Portfolio

Entity Type: 03

Mercy BioAnalytics, Inc. has 23 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). The portfolio includes 0 registered trademarks and 5 pending applications. Filings span 4 Nice Classification classes, led by Class 42 (Computer & Scientific) and Class 10 (Medical Apparatus). This trademark owner is based in Boston, MA.

1 Dalton St. #2605

Boston, MA 02115

23 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Mercy BioAnalytics, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (11 filings)

Scientific and technological services; industrial analysis and research services

10
Medical Apparatus (11 filings)

Surgical, medical, dental and veterinary apparatus and instruments

44
Medical Services (11 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (11 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Mercy BioAnalytics, Inc. have?

Mercy BioAnalytics, Inc. has 23 U.S. trademarks filed with the USPTO. Of these, 5 pending, 18 abandoned.

What trademark classes does Mercy BioAnalytics, Inc. file in?

Mercy BioAnalytics, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What is Mercy BioAnalytics, Inc.'s trademark registration success rate?

Mercy BioAnalytics, Inc. has a 0% trademark registration rate, with 0 out of 18 resolved applications resulting in successful registration. Currently, 5 applications are pending review.